Idecet-AX Tablet Substitute
Composition:
AMBROXOL-60MG + LEVOCETIRIZINE-5MG
Uses:
Chronic bronchitis, chronic obstructive pulmonary disease (COPD), allergic rhinitis and respiratory tract infections, and cough.
Medicinal Benefits:
Idecet-AX Tablet is a combination respiratory medication used to treat symptoms associated with chronic bronchitis, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and respiratory tract infections, such as cough, sneezing, runny nose, and watery eyes. It consists of Levocetirizine (anti-histamine) and Ambroxol (mucolytic agent). Levocetirizine is an antihistamine (anti-allergic) drug that reduces the effects of histamine, a chemical substance that causes allergies like runny nose and skin rash. Ambroxol is a mucolytic agent and an expectorant that works by thinning and loosening phlegm (mucus) in the lungs, windpipe and nose.
Idecet-AX Tablet consists of Levocetirizine and Ambroxol. Levocetirizine is an antihistamine (anti-allergic) drug that reduces the effects of histamine, a chemical substance that causes allergies like runny nose and skin rash. Ambroxol is a mucolytic agent that works by thinning and loosening phlegm (mucus) in lungs, windpipe and nose. Collectively, Idecet-AX Tablet helps relieve respiratory disease associated symptoms like cough, runny nose, and sneezing.
No, you are not recommended to stop taking Idecet-AX Tablet without consulting your doctor as it may worsen the condition or cause recurring symptoms. Therefore, take Idecet-AX Tablet for as long as your doctor has prescribed it, and if you experience any difficulty while taking Idecet-AX Tablet , please consult your doctor.
Yes, Idecet-AX Tablet may cause drowsiness. It is not necessary for everyone taking Idecet-AX Tablet to experience this side effect. Therefore, avoid driving if you feel drowsy after taking Idecet-AX Tablet .
Levocetirizine in Idecet-AX Tablet is contraindicated in patients undergoing dialysis treatment. Please consult your doctor before taking Idecet-AX Tablet in cases of renal impairment.